BRIEF-Uniqure presents updated clinical data in patients with severe Hemophilia B
July 27, 2016 at 19:10 PM EDT
* Uniqure presents updated clinical data in patients with severe Hemophilia B demonstrating up to 9 months of sustained levels of factor IX activity and therapeutic effect Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)
